CCND1 and benign prostatic hyperplasia: Hence, in this study, we aimed to investigate the Cyclin D1 expression in patients with BPH and PC and to correlate the expression with the clinical characteristics of the patients, and to emphasize the use of Cyclin D1 as a diagnostic and prognostic marker for PC in Sudan.